Eli Lilly and Company (LLY)

NYQ – Real Time Price. Currency in USD

1221.27

+6.25 (0.51%)

Market open: Aug 12, 2026, 12:40 PM EDT

1218.00

+2.98 (0.25%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

65.18B

45.04B

34.12B

28.54B

Cost of goods sold

-11.05B

-8.42B

-7.08B

-6.63B

Gross Profit

54.13B

36.62B

27.04B

21.91B

Operating expenses (excl. COGS)

-24.43B

-19.58B

-16.72B

-13.63B

Operating Income

29.70B

17.04B

10.33B

8.28B

Non-operating income, total

-3.96B

-4.36B

-3.77B

-1.47B

Pretax income

25.73B

12.68B

6.55B

6.81B

Equity in earnings

Taxes

-5.09B

-2.09B

-1.31B

-562M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

20.64B

10.59B

5.24B

6.24B

Discontinued operations

Net income

20.64B

10.59B

5.24B

6.24B

Dilution adjustment

Preferred dividends

Eli Lilly and Company (LLY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eli Lilly and Company (LLY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Eli Lilly and Company (LLY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eli Lilly and Company (LLY)

Income Statement (Annual)

Income Statement (Annual)